Back to Latest News
Join us at the Next Generation Cancer Vaccine Development Summit in Boston 16-18th August 2022
Micropore will be presenting at this event uniting senior scientists and oncology specialists who are committed to finding better antigens, more effective vectors, reassessing target patient populations and exploring new platforms with clinical data where CD8 immune responses have been documented to be strong and long lasting.
Micropore will be presenting at this event uniting senior scientists and oncology specialists who are committed to finding better antigens, more effective vectors, reassessing target patient populations and exploring new platforms with clinical data where CD8 immune responses have been documented to be strong and long lasting.
To register for this event go to LINK
Micropore will be presenting at this event uniting senior scientists and oncology specialists who are committed to finding better antigens, more effective vectors, reassessing target patient populations and exploring new platforms with clinical data where CD8 immune responses have been documented to be strong and long lasting.
To register for this event go to LINK
Need a formulation challenge solved? Ask a Micropore expert
At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.
Stay Informed
Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.
Quick Links
Contact
Micropore Technologies
Europe, Middle East, Asia: +(44) 1642 438367
Americas & Canada: +(1) (205) 639 3730
India: +91 (0) 96763 56456
Terms of Use
Accessibility
